RRC ID 18106
著者 Shoji Y, Miyamoto M, Ishikawa K, Yoshioka T, Mishra R, Ichinokawa K, Matsumura Y, Itoh T, Shinohara T, Hirano S, Kondo S.
タイトル The CD40-CD154 interaction would correlate with proliferation and immune escape in pancreatic ductal adenocarcinoma.
ジャーナル J Surg Oncol
Abstract BACKGROUND:CD40 and CD154 are associated with lymphocyte signaling pathways and they are also expressed in some malignant neoplasms, but the significance in pancreatic cancer is unknown.
METHODS:Eighty pancreatic cancer specimens were stained immunohistochemically, and the results were correlated with the patients' clinicopathologic features. Subsequently, in vitro analysis of CD40-CD154 signaling was performed.
RESULT:Immunohistochemical analysis of tumor cells showed that 29 patients (36.3%) were positive for CD40, and 17 patients (21.3%) had very high CD154 expression. The survival of patients who had very high CD154 expression was significantly better than that of others (P = 0.0198). Univariate and multivariate analysis revealed that very high CD154 expression in cancer cells was not an independent, favorable prognostic factor (risk ratio, 0.493; P = 0.0224). On in vitro proliferation assay, the growth of PK-45P and KP-4 cells was blocked by CD40 and CD154 blocking antibodies. Moreover, on in vitro cytokine assay, Th-2 cytokines from PK-45P and SUIT-2 were blocked by CD40 or CD154 blocking antibody.
CONCLUSION:These results suggest that the CD40-CD154 interaction would correlate with cell proliferation and secretion of cytokines in PDAC cells, and CD154 overexpression could be a favorable prognostic factor in PDAC patients.
巻・号 103(3)
ページ 230-8
公開日 2011-3-1
DOI 10.1002/jso.21812
PMID 21337550
MeSH Adenocarcinoma / immunology* Adult Aged Aged, 80 and over CD40 Antigens / immunology CD40 Ligand / immunology Carcinoma, Pancreatic Ductal / immunology* Cell Proliferation Female Humans Male Middle Aged Pancreatic Neoplasms / immunology* Signal Transduction Tumor Escape*
IF 2.771
引用数 9
WOS 分野 SURGERY ONCOLOGY
リソース情報
ヒト・動物細胞 KP4(RCB1005) MIA Paca2(RCB2094) PANC-1(RCB2095) 1C3D3(RCB0796) HeLa(RCB0007)